Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Renalytix plc - Sponsored ADR (RNLXY : OTC)
 
 • Company Description   
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.18 Daily Weekly Monthly
20 Day Moving Average: 54,111 shares
Shares Outstanding: 165.60 (millions)
Market Capitalization: $29.81 (millions)
Beta: 2.27
52 Week High: $0.50
52 Week Low: $0.12
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.53% -19.28%
12 Week -18.18% -30.12%
Year To Date -14.33% -19.75%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2 Leman Street
-
London,X0 E1W 9US
GBR
ph: 44-20-3139-2910
fax: -
investors@renalytix.com http://www.renalytix.com
 
 • General Corporate Information   
Officers
James McCullough - Chief Executive Officer and Chairman of the Board
Thomas McLain - President
O. James Sterling - Chief Financial Officer
Catherine Coste - Director
Daniel Levangie - Director

Peer Information
Renalytix plc - Sponsored ADR (HLIS)
Renalytix plc - Sponsored ADR (AZTA)
Renalytix plc - Sponsored ADR (APYI)
Renalytix plc - Sponsored ADR (RNVA)
Renalytix plc - Sponsored ADR (HMSY)
Renalytix plc - Sponsored ADR (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 75973T101
SIC: 8071
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 09/01/24
Next Expected EPS Date: 09/29/25
Share - Related Items
Shares Outstanding: 165.60
Most Recent Split Date: (:1)
Beta: 2.27
Market Capitalization: $29.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 12.67
EPS Growth
vs. Year Ago Period: 63.64%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 13.73%
vs. Previous Quarter: -10.92%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©